Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Neurol India ; 2006 Jun; 54(2): 200-1
Article in English | IMSEAR | ID: sea-121415

ABSTRACT

Headaches are commonly associated with various psychiatric disorders. The comorbidity of migraine and psychiatric disorders has been well documented. Here we present a case of schizophrenia with comorbid headache treated with clozapine. The patient's headache fulfilled the diagnostic criteria for cluster headache (CH). To our knowledge this is the first report of CH responding to clozapine therapy. The relationship of headache and psychiatric disorders is a matter of debate and there has been very little research on the aspect of causality or direction of causation. The response of both the conditions to a serotonin-dopamine antagonist such as clozapine might be important in giving newer insights into the pathogenesis of these disorders. It also has the clinical implication of being useful in patients with dual diagnosis.


Subject(s)
Adult , Antipsychotic Agents/therapeutic use , Clozapine/therapeutic use , Cluster Headache/complications , Female , Humans , Schizophrenia/complications
2.
Neurol India ; 2006 Jun; 54(2): 205-6
Article in English | IMSEAR | ID: sea-121382

ABSTRACT

We report a 19-year-old man presenting to the department of Psychiatry for the evaluation of prominent behavioral symptoms associated with episodic headaches, with normal inter-episodic periods. A diagnosis of classic migraine with hypomanic aura was made. Other possible co-morbid or causative illnesses were excluded and preventive therapy with valproate was started due to the prominent affective symptoms as a part of the migranous aura. With this the frequency of headaches gradually decreased over the next four months. He was followed up for 2 years when he was found to be symptom-free. Recent research into the mechanisms of migraine has identified that the cortical hyperexcitability and an imbalance between neuronal inhibition and excitement mediated by gamma-aminobutyric acid and excitatory amino acids respectively may be the underlying mechanism. The high rate of affective disorders in patients with migraine, association of migraine with an aura comprising of mood symptoms and good response to treatment with mood-stabilisers might give newer insights into the pathophysiology of mood disorder as well.


Subject(s)
Adult , Antimanic Agents/therapeutic use , Bipolar Disorder/drug therapy , Electroencephalography , Humans , Male , Migraine with Aura/drug therapy , Valproic Acid/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL